Literature DB >> 13719955

Inactivated influenza virus vaccines. Past, present, and future.

F M DAVENPORT.   

Abstract

Entities:  

Keywords:  INFLUENZA/immunology

Mesh：

Substances：

Year:  1961        PMID： 13719955     DOI： 10.1164/arrd.1961.83.2P2.146

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  9 in total

1.  [COMPARATIVE IMMUNITY TESTS ON MICE WITH DIFFERENT INFLUENZA VACCINES].

Authors:  K HERZBERG; K REUSS; R DAHN
Journal:  Z Hyg Infektionskr       Date:  1964-04-13

2.  THE EPIDEMIOLOGICAL BASIS FOR THE CONTROL OF INFLUENZA.

Authors:  A D LANGMUIR; D A HENDERSON; R E SERFLING
Journal:  Am J Public Health Nations Health       Date:  1964-04

3.  II. EFFICACY OF ADJUVANT AND AQUEOUS ADENOVIRUS VACCINES IN PREVENTION OF NAVAL RECRUIT RESPIRATORY DISEASE.

Authors:  L F MILLER; R O PECKINPAUGH; T R ARLANDER; W E PIERCE; E A EDWARDS; P DEBERRY; I A PHILLIPS; M J ROSENBAUM
Journal:  Am J Public Health Nations Health       Date:  1965-01

4.  Clinically distinguishable syndromes caused by viruses.

Authors:  R E Haynes; P H Azimi; H G Cramblett; M D Hilty; D L Burech; K I Koranyi
Journal:  Curr Probl Pediatr       Date:  1975-04

5.  Potentiation of tissue culture rabies vaccine by adjuvants.

Authors:  P Fenje; L Pinteric
Journal:  Am J Public Health Nations Health       Date:  1966-12

6.  The 2009 H1N1 pandemic influenza virus: what next?

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  MBio       Date:  2010-09-28       Impact factor: 7.867

7.  The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus.

Authors:  J C Downie; C H Stuart-Harris
Journal:  J Hyg (Lond)       Date:  1970-06

8.  Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses.

Authors:  M Hamzawi; R Jennings; C W Potter
Journal:  J Hyg (Lond)       Date:  1981-12

9.  Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.

Authors:  Veronika I Zarnitsyna; Irina Bulusheva; Andreas Handel; Ira M Longini; M Elizabeth Halloran; Rustom Antia
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.